Data / Form D filings / OnKure, Inc.
OnKure, Inc.: Form D filings
OnKure, Inc., a pharmaceuticals company in Boulder, CO, filed 14 Form D notices with the SEC between 2011 and 2023. The latest, on April 3, 2023, reports $53.8 million sold of a $60 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6707 WINCHESTER CIRCLE, SUITE 400, Boulder, CO, 80301
- Phone
- (720) 307-2892
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1533914
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | New notice | $60,000,000 | $53,783,369 | $6,216,631 | 15 | Mar 24, 2023 | sec.gov |
| Mar 4, 2022 | Amendment | $56,649,181 | $56,649,181 | 11 | Mar 3, 2021 | sec.gov | |
| Mar 5, 2021 | New notice | $56,649,181 | $29,149,185 | $27,499,996 | 11 | Mar 3, 2021 | sec.gov |
| Sep 30, 2020 | Amendment | $2,000,000 | $1,500,000 | $500,000 | 2 | Aug 4, 2020 | sec.gov |
| Aug 6, 2020 | New notice | $2,000,000 | $1,000,000 | $1,000,000 | 1 | Aug 4, 2020 | sec.gov |
| Apr 15, 2020 | New notice | $5,236,935 | $3,236,935 | $2,000,000 | 6 | Apr 15, 2020 | sec.gov |
| Mar 6, 2020 | New notice | $2,000,000 | $1,000,000 | $1,000,000 | 1 | Mar 4, 2020 | sec.gov |
| Sep 20, 2019 | New notice | $2,000,000 | $100,000 | $1,900,000 | 1 | Sep 20, 2019 | sec.gov |
| Feb 8, 2018 | New notice | $4,957,450 | $4,957,450 | 16 | Feb 6, 2018 | sec.gov | |
| Jun 8, 2017 | Amendment | $1,000,000 | $855,000 | $145,000 | 8 | Jun 26, 2015 | sec.gov |
| Jul 7, 2015 | New notice | $1,000,000 | $495,000 | $505,000 | 7 | Jun 26, 2015 | sec.gov |
| Jun 4, 2013 | New notice | $599,705 | $599,705 | 2 | Jun 4, 2013 | sec.gov | |
| Apr 9, 2013 | Amendment | $499,985 | $499,985 | 1 | Oct 20, 2011 | sec.gov | |
| Oct 31, 2011 | New notice | $499,985 | $99,997 | $399,988 | 1 | Oct 20, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anthony D. Piscopio | Executive Officer, Director | |
| R. Michael Carruthers | Director | |
| Andrew J. Phillips | Director | |
| Isaac Michael Manke | Director | |
| Nicholas M. Saccomano | Director | |
| Duncan M. Walker | Executive Officer | |
| James M. Winkler | Executive Officer | |
| Jason M. Leverone | Executive Officer | |
| Keith M. Olivia | Executive Officer |
Every Form D from the week of Apr 3, 2023 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what OnKure, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.